Kerala health department issues COVID-19 guidelines, instructs hospitals to conduct mock drills
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
In view of the increase in the number of COVID-19 cases in Kerala , the state health department issued guidelines to hospitals and health workers. It has also directed the government and private hospitals to conduct mock drills.The Kerala health department will provide a Google Form for conducting an online mock drill.The health department instructed the hospitals to follow the revised ABC Guidelines 03, issued in June 2023, while treating patients with COVID-19 and influenza symptoms.The guidelines said that it is necessary to pay attention to whether there are any red flag signs in patients with COVID-19 and influenza symptoms. The red flag signs to be monitored are breathlessness, chest pain, drowsiness, fall in blood pressure, hemoptysis, cyanosis. Symptoms to watch for in children include somnolence, high persistent fever, inability to feed well, convulsions, dyspnoea, and respiratory distress.The health department asked the high-risk individuals to wear masks in public places. Those with symptoms such as a cold, sore throat, cough, and shortness of breath should wear masks if they are in relief camps.The health department instructed groups at risk of becoming seriously ill if infected with COVID-19 to be especially careful. Elderly, pregnant women, and those with serious illnesses should wear masks. If they have any symptoms, they should inform the health department.If anyone is diagnosed with COVID-19, treatment should be ensured as per the protocol.As per the health department, all hospitalised patients with ILI/ARI/SARI symptoms should be tested for COVID-19. If the Rapid Antigen Test is negative, the RT-PCR test should be done.The hospitals are urged to keep COVID-19 and influenza patients in separate wards or rooms in hospitals, and patients, their companions, and all health workers in hospitals are instructed to wear masks.The number of bystanders and visitors in hospitals should be controlled, and a COVID-19 test should be conducted for bystanders and health workers with symptoms.The state health department instructed RT-PCR facilities in districts to be used to the maximum extent for COVID-19 testing, and practices such as mask use, cough hygiene, and hand washing to be promoted in public places.A guideline has been issued for the hospital facilities that urgently need to be adequately equipped. Availability of Oxygen supply, medicines, personal protective gear (N95 masks, gloves and aprons), oxygen-supported beds, ventilators and ICU beds should be ensured.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
28 minutes ago
- Business Standard
Long-Covid, viruses: New research looks for links to chronic fatigue
Millions of people who recover from infections like Covid-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise. Medically the symptoms are known as myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). The World Health Organization classifies this as a post viral fatigue syndrome, and it is recognised by both the WHO and the United States Centers for Disease Control and Prevention as a brain disorder. Experiencing illness long after contracting an infection is not new, as patients have reported these symptoms for decades. But Covid-19 has amplified the problem worldwide. Nearly half of people with ongoing post-Covid symptoms – a condition known as long-Covid– now meet the criteria for ME/CFS. Since the start of the pandemic in 2020, it is estimated that more than 400 million people have developed long-Covid. To date, no widely accepted and testable mechanism has fully explained the biological processes underlying long-Covid and ME/CFS. Our work offers a new perspective that may help close this gap. Our research group studies blood and the cardiovascular system in inflammatory diseases, as well as post-viral conditions. We focus on coagulation, inflammation and endothelial cells. Endothelial cells make up the inner layer of blood vessels and serve many important functions, like regulating blood clotting, blood vessel dilation and constriction, and inflammation. Our latest review aims to explain how ME/CFS and long-Covid start and progress, and how symptoms show up in the body and its systems. By pinpointing and explaining the underlying disease mechanisms, we can pave the way for better clinical tools to diagnose and treat people living with ME/CFS and long-Covid. What is endothelial senescence? In our review, our international team proposes that certain viruses drive endothelial cells into a half-alive, 'zombie-like' state called cellular senescence. Senescent endothelial cells stop dividing, but continue to release molecules that awaken and confuse the immune system. This prompts the blood to form clots and, at the same time, prevent clot breakdown, which could lead to the constriction of blood vessels and limited blood flow. By placing 'zombie' blood-vessel cells at the centre of these post-viral diseases, our hypothesis weaves together microclots, oxygen debt (the extra oxygen your body needs after strenuous exercise to restore balance), brain-fog, dizziness, gut leakiness (a digestive condition where the intestinal lining allows toxins into the bloodstream) and immune dysfunction into a single, testable narrative. From acute viral infection to 'zombie' vessels Viruses like SARS-CoV-2, Epstein–Barr virus, HHV-6, influenza A, and enteroviruses (a group of viruses that cause a number of infectious illnesses which are usually mild) can all infect endothelial cells. They enable a direct attack on the cells that line the inside of blood vessels. Some of these viruses have been shown to trigger endothelial senescence. Multiple studies show that SARS-CoV-2 (the virus which causes Covid-19 disease) has the ability to induce senescence in a variety of cell types, including endothelial cells. Viral proteins from SARS-CoV-2, for example, sabotage DNA-repair pathways and push the host cell towards a senescent state, while senescent cells in turn become even more susceptible to viral entry. This reciprocity helps explain why different pathogens can result in the same chronic illness. Influenza A, too, has shown the ability to drive endothelial cells into a senescent, zombie-like state. What we think is happening We propose that when blood-vessel cells turn into 'zombies', they pump out substances that make blood thicker and prone to forming tiny clots. These clots slow down circulation, so less oxygen reaches muscles and organs. This is one reason people feel drained. During exercise, the problem worsens. Instead of the vessels relaxing to allow adequate bloodflow, they tighten further. This means that muscles are starved of oxygen and patients experience a crash the day after exercise. In the brain, the same faulty cells let blood flow drop and leak, bringing on brain fog and dizziness. In the gut, they weaken the lining, allowing bits of bacteria to slip into the bloodstream and trigger more inflammation. Because blood vessels reach every corner of the body, even scattered patches of these 'zombie' cells found in the blood vessels can create the mix of symptoms seen in long-Covid and ME/CFS. Immune exhaustion locks in the damage Some parts of the immune system kill senescent cells. They are natural-killer cells, macrophages and complement proteins, which are immune molecules capable of tagging and killing pathogens. But long-Covid and ME/CFS frequently have impaired natural-killer cell function, sluggish macrophages and complement dysfunction. Senescent endothelial cells may also send out a chemical signal to repel immune attack. So the 'zombie cells' actively evade the immune system. This creates a self-sustaining loop of vascular and immune dysfunction, where senescent endothelial cells persist. In a healthy person with an optimally functioning immune system, these senescent endothelial cells will normally be cleared. But there is significant immune dysfunction in ME/CFS and long-Covid, and this may enable the 'zombie cells' to survive and the disease to progress. Where the research goes next There is a registered clinical trial in the US that is investigating senescence in long-Covid. Our consortium is testing new ways to spot signs of ageing in the cells that line our blood vessels. First, we expose healthy endothelial cells in the lab to blood from patients to see whether it pushes the cells into a senescent, or 'zombie,' state. At the same time, we are trialling non-invasive imaging and fluorescent probes that could one day reveal these ageing cells inside the body. In selected cases, tissue biopsies may later confirm what the scans show. Together, these approaches aim to pinpoint how substances circulating in the blood drive cellular ageing and how that, in turn, fuels disease. Our aim is simple: find these ageing endothelial cells in real patients. Pinpointing them will inform the next round of clinical trials and open the door to therapies that target senescent cells directly, offering a route to healthier blood vessels and, ultimately, lighter disease loads.
Time of India
32 minutes ago
- Time of India
America is slipping behind India's clean power boom
Bloomberg Live Events Bloomberg Bloomberg (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Once upon a time, the US was the sole clean energy superpower . Until 2011, it led the world in connecting wind and solar generators to the grid. Then China took over, to a point where its lead now looks unassailable: The People's Republic added eight times more renewables than the US last year. This year, India is likely to overtake country connected 22 gigawatts of wind and solar in the first half — a dramatic recovery from a troubling slowdown in 2022 and 2023, and enough at full output to power nearly one-tenth of the grid. Assuming this is maintained through December, that should put India ahead of the 40 GW that the US government expects this also setting the world's most populous nation on course to hit a target of Prime Minister Narendra Modi's that once seemed implausible: to reach 500 GW of non-fossil generation by 2030. Such a shift will herald the dawn of a new clean energy superpower, and give the world some of its best hopes of averting disastrous climate a remarkable turnaround for a country whose renewable industry looked like a lost cause barely more than a year ago. What happened?One factor is financing. Easing inflation has allowed the Reserve Bank of India to cut its policy rate by a percentage point since December to the lowest in three years. This reduces the price of renewables, which are particularly exposed to debt costs. Regulatory deadlines have also played a role: A waiver on transmission charges for wind and solar expired at the end of last month, causing developers to rush to complete their builds in time to get the financial end of that waiver may cause a wobble for the sector over the next year or so, but the changes will be introduced slowly. Over the balance of the decade there's now good reason to think the recent pace can be sustained. The rash of projects breaking ground this past year means about 414 GW of clean power is already either operating or under construction, including nuclear and hydroelectric plants. That's not far off the 500 GW target, and we've still got more than five years to are counting on it. Solar panel manufacturing has been ramping up to the point where it now runs far in excess of domestic demand, at 91 GW. With lower tariffs into the US than their rivals in China and Southeast Asia, this excess of supply might make local panel makers rare beneficiaries of President Donald Trump's war on clean energy. That certainly seems to be the assumption of a group of US competitors, who last week sought anti-dumping measures to keep Indian products out of their many years, India had a skeptical take on the energy transition, arguing since the 1970s that poverty was a more pressing problem than protecting the environment. The difference now is that zero-carbon power is decisively cheaper than the competition. Rising incomes, meanwhile, mean the government needs to also think about the needs of roughly half a billion middle-class citizens, who worry more about where to find a good job in a clean, livable city than the basics of subsistence is still building coal-fired power plants to make sure those newly-minted urbanites don't suffer power cuts in the middle of punishing heatwaves, but they're not necessarily being used. Thanks to milder weather than in recent years and the rising volumes of renewables pushing it off the grid, fossil-fired power generation fell 4% in the first half relative to 2024. That's the first time it has dropped since the Covid-19 pandemic hit in 2020, and occurred even as electricity generation rose 0.8%. Retirements of old plants mean that fossil-generation capacity has actually declined slightly so far this still possible that emissions from India's power sector won't peak until well into the 2030s. Even so, the faster rollout of renewables, combined with declining pollution from China and the rich world, means the global picture is improving faster than you'd realize if you were focused only on the steampunk posturing in power isn't just cleaner — it's cheaper, and more suited to the aspirations of the billions in the Global South who want a better, healthier nations like the US can afford the indulgence of a campaign against modern energy, at least until their citizens realize how badly they're being shortchanged. It's a fatal myopia, though. For all Trump likes to boast of energy dominance, America is falling behind on the most important energy technologies of the 21st century.
Time of India
4 hours ago
- Time of India
Italy PM Meloni says it's a 'positive' trade deal was reached but needs to see details
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Italy's Prime Minister Giorgia Meloni said on Sunday it is "positive" a trade deal has been reached between the European Union and the United States, adding, however, that she needs to see the struck a framework trade deal with the EU imposing a 15% import tariff on most EU goods."I consider it positive that there is an agreement, but if I don't see the details I am not able to judge it in the best way," Meloni told journalists on the sidelines of a meeting in Addis is one of the biggest European exporters to the U.S., with a trade surplus of more than 40 billion Italian government, led by a nationalist coalition, had urged its European partners to avoid a direct clash between the two sides of the a statement, Meloni said that the agreement "ensures stability", adding that the 15% "is sustainable, especially if this percentage is not added to previous duties, as was originally planned.""We are ready to activate support measures at the national level, but we ask that they also be activated at the European level for sectors that will be particularly affected by US tariff measures," she statement was also signed by the leaders of the other two coalition parties: Antonio Tajani of Forza Italia and Matteo Salvini of the League.
